Pay in 4 interest-free payments of $6.84 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Food and Drug Administrations (FDA) drug shortage list, 503B outsourcing facilities and 503A compounding pharmacies stepped in to fill the gap, compounding patient-specific or office-use formulations to meet patient needs
Adjacent human safety: Increlex (mecasermin) FDA label 71 pediatric patients with severe primary IGFD treated for a mean of 3.9 years
In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Mirzaa GM, Amemiya A, editors
Short-term results are real, but long-term use can bring side effects and dependency
US$ 22.77
US$ 23.82
US$ 20.41
US$ 27.92
US$ 25.87
US$ 24.57
US$ 22.25
